22157.jpg
CD40 Agonists & CD40/Ligand Antagonists Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
October 24, 2024 10:14 ET | Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
GMILogo_Vertical-Gradient.png
Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.
October 01, 2024 05:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Immune Checkpoint Inhibitors Market size reached USD 47.4 billion in 2023 and is projected to register a CAGR of 16.7% from 2024 to 2032...
22157.jpg
Announcing the 2nd Annual ImmunoBio Series Conference: A Nexus of Biomarker Insights and Immuno-Oncology Innovations (Germany, 14th-15th October 2024)
July 12, 2024 11:05 ET | Research and Markets
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "2nd Annual ImmunoBio Series" conference has been added to ResearchAndMarkets.com's offering. Introducing the 2nd Annual ImmunoBio Series, a...
22157.jpg
CCR8 Targeted Antibody Immunotherapy Pipeline Review 2024: An Emerging, Highly Attractive Next Generation Immuno-oncology Target
July 08, 2024 04:08 ET | Research and Markets
Dublin, July 08, 2024 (GLOBE NEWSWIRE) -- The "CCR8-Targeted Antibody Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. CCR8 is an emerging, highly...
22157.jpg
Global Oncolytic Virus Therapy Industry Research 2024-2032: Strategic Collaborations to Increase Market Share, Oncolytic Wild-type Viruses Driving Therapeutic Innovation, North America Leads
June 27, 2024 06:03 ET | Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
22157.jpg
Malignant Mesothelioma Pipeline Landscape Analysis, 2024 - Incyte's INCB001158 and Polaris' Pegargiminase Lead the Way in Mechanism-Specific Interventions
June 07, 2024 09:19 ET | Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Malignant Mesothelioma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been...
22157.jpg
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
May 28, 2024 09:06 ET | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
22157.jpg
Histone Deacetylase 6 Drug Pipeline Research Report 2024: Comprehensive Insights about 20+ Companies and 26+ Pipeline Drugs
April 12, 2024 10:06 ET | Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029: 800+ Bispecific Candidates Currently in Active Clinical Development
March 18, 2024 05:16 ET | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
22157.jpg
Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares
March 07, 2024 12:09 ET | Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Oncology-based In-Vivo CRO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Industry Anticipates Major...